Monday, December 27, 2010

Terbigen




Terbigen may be available in the countries listed below.


Ingredient matches for Terbigen



Terbinafine

Terbinafine hydrochloride (a derivative of Terbinafine) is reported as an ingredient of Terbigen in the following countries:


  • Hungary

  • Poland

International Drug Name Search

Friday, December 24, 2010

Lipathrec




Lipathrec may be available in the countries listed below.


Ingredient matches for Lipathrec



Glucosamine

Glucosamine is reported as an ingredient of Lipathrec in the following countries:


  • Greece

International Drug Name Search

Wednesday, December 22, 2010

Cypestra-35




Cypestra-35 may be available in the countries listed below.


Ingredient matches for Cypestra-35



Cyproterone

Cyproterone 17α-acetate (a derivative of Cyproterone) is reported as an ingredient of Cypestra-35 in the following countries:


  • Switzerland

Ethinylestradiol

Ethinylestradiol is reported as an ingredient of Cypestra-35 in the following countries:


  • Switzerland

International Drug Name Search

Magnesio carbonato + acido citrico Zeta




Magnesio carbonato + acido citrico Zeta may be available in the countries listed below.


Ingredient matches for Magnesio carbonato + acido citrico Zeta



Citric Acid

Citric Acid anhydrous (a derivative of Citric Acid) is reported as an ingredient of Magnesio carbonato + acido citrico Zeta in the following countries:


  • Italy

Magnesium Carbonate

Magnesium Carbonate light (a derivative of Magnesium Carbonate) is reported as an ingredient of Magnesio carbonato + acido citrico Zeta in the following countries:


  • Italy

International Drug Name Search

Tuesday, December 21, 2010

Durabac Forte


Pronunciation: ah-seet-ah-MIN-oh-fen/ka-FEEN/mag-NEE-zhum sa-LI-si-late/fen-ill-tole-OX-a-meen
Generic Name: Acetaminophen/Caffeine/Magnesium Salicylate/Phenyltoloxamine
Brand Name: Durabac Forte


Durabac Forte is used for:

Treating mild to moderate aches and pains associated with headache, muscle and joint soreness, muscle spasms, nerve pain, menstrual cramps, colds and flu, sinusitis, toothache, and minor pain from arthritis. It helps restore mental alertness or wakefulness during periods of fatigue or drowsiness. It may also be used for other conditions as determined by your doctor.


Durabac Forte is an analgesic, antipyretic, salicylate, antihistamine, and stimulant combination. It works by decreasing fever, pain, and inflammation. It also blocks histamine, which causes allergy symptoms (eg, sneezing and itchy, watery eyes).


Do NOT use Durabac Forte if:


  • you are allergic to any ingredient in Durabac Forte

  • you are allergic to salicylates (eg, aspirin) or NSAIDs (eg, ibuprofen)

  • you have kidney or liver problems, bleeding problems (eg, hemophilia, active severe bleeding), low blood platelet levels, or Von Willebrand disease

  • the patient is a child or teenager who has flu symptoms or chickenpox

  • you are also taking an anticoagulant (eg, warfarin) or sodium oxybate (GHB)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Durabac Forte:


Some medical conditions may interact with Durabac Forte. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have breathing problems (eg, asthma), blood clotting problems, stomach or intestinal problems (eg, ulcer, blockage, inflammation), prostate problems, urinary blockage, trouble urinating, increased pressure in the eyes (eg, glaucoma), heart or blood vessel problems, high blood pressure, viral hepatitis, anxiety, trouble sleeping, growths in the nose, low blood vitamin K levels, influenza, or chickenpox

  • if the patient is a child who has a history of stroke, a bulging blood vessel in the brain (aneurysm), an inflammatory condition (rheumatic disease), or Kawasaki syndrome

  • if you have taken furazolidone or a monamine oxidase (MAO) inhibitor (eg, phenelzine) within the past 14 days

Some MEDICINES MAY INTERACT with Durabac Forte. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Carbonic anhydrase inhibitors (eg, acetazolamide), insulin, meglitinides (eg, nateglinide), sodium oxybate (GHB), sympathomimetics (eg, albuterol, pseudoephedrine), theophyllines (eg, aminophylline), or valproic acid because the risk of their side effects may be increased by Durabac Forte

  • Anticoagulants (eg, warfarin) because the risk of bruising or bleeding may be increased

  • Barbiturates (eg, phenobarbital) because they may decrease Durabac Forte's effectiveness

  • Medicines that may harm the liver (eg, acetaminophen, methotrexate, ketoconazole, isoniazid, certain medicines for HIV infection) because the risk of liver side effects may be increased. Ask your doctor if you are unsure if any of your medicines might harm the liver.

  • Furazolidone, isoniazid, MAO inhibitors (eg, phenelzine), or quinolone antibiotics (eg, ciprofloxacin) because they may increase the risk of Durabac Forte's side effects

  • Angiotensin-converting enzyme (ACE) inhibitors (eg, enalapril), aspirin, probenecid, or sulfinpyrazone because their effectiveness may be decreased by Durabac Forte

This may not be a complete list of all interactions that may occur. Ask your health care provider if Durabac Forte may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Durabac Forte:


Use Durabac Forte as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Take Durabac Forte by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.

  • If you miss a dose of Durabac Forte and you are using it regularly, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Durabac Forte.



Important safety information:


  • Durabac Forte may cause drowsiness, dizziness, or blurred vision. These effects may be worse if you take it with alcohol or certain medicines. Use Durabac Forte with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Durabac Forte; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Durabac Forte may harm your liver. Your risk may be greater if you drink alcohol while you are using Durabac Forte. Talk to your doctor before you take Durabac Forte or other fever reducers if you drink more than 3 drinks with alcohol per day.

  • Durabac Forte has a salicylate in it. Before you start any new medicine, check the label to see if it has a salicylate in it too. If it does or if you are not sure, check with your doctor or pharmacist.

  • Durabac Forte has acetaminophen in it. Before you start any new medicine, check the label to see if it has acetaminophen in it too. If it does or if you are not sure, check with your doctor or pharmacist.

  • Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.

  • Avoid large amounts of food or drink that have caffeine (eg, coffee, tea, cocoa, cola, chocolate).

  • Diabetes patients - Durabac Forte may affect your blood sugar. Check blood sugar levels closely. Ask your doctor before you change the dose of your diabetes medicine.

  • If you are taking Durabac Forte for pain and your symptoms do not improve within 10 days or if they become worse or if redness is present, check with your doctor.

  • Tell your doctor or dentist that you take Durabac Forte before you receive any medical or dental care, emergency care, or surgery.

  • Durabac Forte has a salicylate in it, which has been linked to a serious illness called Reye syndrome. Do not give Durabac Forte to a child or teenager who has the flu, chickenpox, or a viral infection. Contact your doctor with any questions or concerns.

  • Durabac Forte may interfere with certain lab tests. Be sure your doctor and lab personnel know you are taking Durabac Forte.

  • Use Durabac Forte with caution in the ELDERLY; they may be more sensitive to its effects, especially anemia or liver or kidney problems.

  • Durabac Forte should be used with extreme caution in CHILDREN younger than 12 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: It is not known if Durabac Forte can cause harm to the fetus. If you become pregnant, contact your doctor. You will need to discuss the benefits and risks of using Durabac Forte while you are pregnant. Durabac Forte is found in breast milk. Do not breast-feed while taking Durabac Forte.


Possible side effects of Durabac Forte:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Anxiety; blurred vision; diarrhea; dizziness; drowsiness; dry mouth, nose, or throat; fast heartbeat; headache; heartburn; irritability; loss of appetite; nausea; nervousness; thickening of mucus in the nose and throat; trouble sleeping; upset stomach; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bloody or black stools; confusion; dark urine or pale stools; decreased coordination; decreased urination; difficulty swallowing; fainting; fever, chills, persistent sore throat, or other signs of infection; hearing loss; hoarseness; irregular heartbeat; muscle weakness; ringing in the ears; seizures; severe or persistent heartburn; severe, persistent, or recurring fast heartbeat; severe stomach pain; severe vomiting; shortness of breath; tremors; unusual bruising or bleeding; unusual tiredness; vomit that looks like coffee grounds; yellowing of the skin or eyes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Durabac Forte side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include abnormal behavior; confusion; dark urine; delirium; difficulty hearing; excessive sweating; extreme tiredness; fast or deep breathing; loss of consciousness; ringing in the ears; seizures; severe or persistent dizziness, nausea, or vomiting; stomach pain; yellowing of the skin or eyes.


Proper storage of Durabac Forte:

Store Durabac Forte at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Do not store in the bathroom. Keep Durabac Forte out of the reach of children and away from pets.


General information:


  • If you have any questions about Durabac Forte, please talk with your doctor, pharmacist, or other health care provider.

  • Durabac Forte is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Durabac Forte. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Durabac Forte resources


  • Durabac Forte Side Effects (in more detail)
  • Durabac Forte Use in Pregnancy & Breastfeeding
  • Durabac Forte Drug Interactions
  • Durabac Forte Support Group
  • 0 Reviews for Durabac Forte - Add your own review/rating


Compare Durabac Forte with other medications


  • Pain

Lafax




Lafax may be available in the countries listed below.


Ingredient matches for Lafax



Venlafaxine

Venlafaxine hydrochloride (a derivative of Venlafaxine) is reported as an ingredient of Lafax in the following countries:


  • Bangladesh

International Drug Name Search

Monday, December 20, 2010

Wormin




Wormin may be available in the countries listed below.


Ingredient matches for Wormin



Mebendazole

Mebendazole is reported as an ingredient of Wormin in the following countries:


  • Eritrea

  • Ethiopia

  • India

  • Kenya

  • Latvia

  • Nigeria

  • Russian Federation

  • Tanzania

  • Uganda

  • Zambia

  • Zimbabwe

International Drug Name Search

Thursday, December 16, 2010

Tetrazepam beta




Tetrazepam beta may be available in the countries listed below.


Ingredient matches for Tetrazepam beta



Tetrazepam

Tetrazepam is reported as an ingredient of Tetrazepam beta in the following countries:


  • Germany

International Drug Name Search

Sunday, December 12, 2010

Doxazosine Teva




Doxazosine Teva may be available in the countries listed below.


Ingredient matches for Doxazosine Teva



Doxazosin

Doxazosin mesilate (a derivative of Doxazosin) is reported as an ingredient of Doxazosine Teva in the following countries:


  • France

International Drug Name Search

Saturday, December 11, 2010

Haloperil




Haloperil may be available in the countries listed below.


Ingredient matches for Haloperil



Haloperidol

Haloperidol is reported as an ingredient of Haloperil in the following countries:


  • Mexico

International Drug Name Search

Friday, December 10, 2010

Carbenin




Carbenin may be available in the countries listed below.


Ingredient matches for Carbenin



Betamipron

Betamipron is reported as an ingredient of Carbenin in the following countries:


  • Japan

Panipenem

Panipenem is reported as an ingredient of Carbenin in the following countries:


  • Japan

International Drug Name Search

Diprofol




Diprofol may be available in the countries listed below.


Ingredient matches for Diprofol



Propofol

Propofol is reported as an ingredient of Diprofol in the following countries:


  • Israel

International Drug Name Search

RamiLich




RamiLich may be available in the countries listed below.


Ingredient matches for RamiLich



Ramipril

Ramipril is reported as an ingredient of RamiLich in the following countries:


  • Germany

International Drug Name Search

Thursday, December 9, 2010

Dezor




Dezor may be available in the countries listed below.


Ingredient matches for Dezor



Ketoconazole

Ketoconazole is reported as an ingredient of Dezor in the following countries:


  • Ethiopia

  • Myanmar

  • Singapore

International Drug Name Search

Wednesday, December 8, 2010

Ciprofloxacine Qualimed




Ciprofloxacine Qualimed may be available in the countries listed below.


Ingredient matches for Ciprofloxacine Qualimed



Ciprofloxacin

Ciprofloxacin hydrochloride (a derivative of Ciprofloxacin) is reported as an ingredient of Ciprofloxacine Qualimed in the following countries:


  • France

International Drug Name Search

Sunday, December 5, 2010

Nitroglycerine




Nitroglycerine may be available in the countries listed below.


Ingredient matches for Nitroglycerine



Nitroglycerin

Nitroglycerin is reported as an ingredient of Nitroglycerine in the following countries:


  • Japan

  • Netherlands

International Drug Name Search

Saturday, December 4, 2010

Finpecia




Finpecia may be available in the countries listed below.


Ingredient matches for Finpecia



Finasteride

Finasteride is reported as an ingredient of Finpecia in the following countries:


  • South Africa

International Drug Name Search

Friday, November 26, 2010

Respiram




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Respiram



Doxapram

Doxapram hydrochloride (a derivative of Doxapram) is reported as an ingredient of Respiram in the following countries:


  • United States

International Drug Name Search

Fluoxetina Normon




Fluoxetina Normon may be available in the countries listed below.


Ingredient matches for Fluoxetina Normon



Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluoxetina Normon in the following countries:


  • Costa Rica

  • Dominican Republic

  • El Salvador

  • Guatemala

  • Honduras

  • Nicaragua

  • Panama

  • Spain

International Drug Name Search

Sunday, November 21, 2010

Osteomerck




Osteomerck may be available in the countries listed below.


Ingredient matches for Osteomerck



Calcium Phosphate

Calcium Phosphate is reported as an ingredient of Osteomerck in the following countries:


  • Spain

Colecalciferol

Colecalciferol is reported as an ingredient of Osteomerck in the following countries:


  • Spain

International Drug Name Search

Thursday, November 18, 2010

Symadal




Symadal may be available in the countries listed below.


Ingredient matches for Symadal



Dimeticone

Dimeticone is reported as an ingredient of Symadal in the following countries:


  • Germany

International Drug Name Search

Wednesday, November 17, 2010

Oxaliplatine Ebewe




Oxaliplatine Ebewe may be available in the countries listed below.


Ingredient matches for Oxaliplatine Ebewe



Oxaliplatin

Oxaliplatin is reported as an ingredient of Oxaliplatine Ebewe in the following countries:


  • France

International Drug Name Search

Dimeflina




Dimeflina may be available in the countries listed below.


Ingredient matches for Dimeflina



Dimefline

Dimeflina (DCIT) is also known as Dimefline (Rec.INN)

International Drug Name Search

Glossary

DCITDenominazione Comune Italiana
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Tuesday, November 16, 2010

Insulin Resistance Syndrome (Metabolic Syndrome) Medications


Definition of Insulin Resistance Syndrome: Many people with noninsulin-dependent diabetes produce enough insulin, but their bodies do not respond to the action of insulin. This may happen because the person is overweight and has too many fat cells, which do not respond well to insulin. Also, as people age, their body cells lose some of the ability to respond to insulin. Insulin resistance is also linked to high blood pressure and high levels of fat in the blood. Another kind of insulin resistance may happen in some people who take insulin injections. They may have to take very high doses of insulin every day

Drugs associated with Insulin Resistance Syndrome

The following drugs and medications are in some way related to, or used in the treatment of Insulin Resistance Syndrome. This service should be used as a supplement to, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

See sub-topics

Topics under Insulin Resistance Syndrome

  • Glucagonoma (2 drugs)

Learn more about Insulin Resistance Syndrome (Metabolic Syndrome)





Drug List:

Wednesday, November 10, 2010

Celoop




Celoop may be available in the countries listed below.


Ingredient matches for Celoop



Teprenone

Teprenone is reported as an ingredient of Celoop in the following countries:


  • Japan

International Drug Name Search

doxorubicin Intravenous


dox-oh-ROO-bi-sin


Intravenous route(Solution;Powder for Solution)

Severe local tissue necrosis will occur if there is extravasation during administration; do not administer by the intramuscular or subcutaneous route. Myocardial toxicity manifested in its most severe form by potentially fatal congestive heart failure (CHF) may occur either during therapy or months to years after termination of therapy. The risk of developing CHF increases rapidly with increasing total cumulative doses of doxorubicin in excess of 400 mg/m(2). Secondary acute myelogenous leukemia (AML) and myelodysplastic syndrome (MDS) have been reported in patients treated with anthracyclines. Pediatric patients are also at risk for developing secondary AML. Reduce dosage in patients with impaired hepatic function. Severe myelosuppression may occur with therapy .



Commonly used brand name(s)

In the U.S.


  • Adriamycin

Available Dosage Forms:


  • Powder for Solution

  • Solution

Therapeutic Class: Antineoplastic Agent


Chemical Class: Anthracycline


Uses For doxorubicin


Doxorubicin belongs to the general group of medicines known as antineoplastics. It is used to treat some kinds of cancers of the blood; lymph system; bladder; breast; stomach; lung; ovaries; thyroid; nerves; kidneys; bones; and soft tissues, including muscles and tendons. It may also be used to treat other kinds of cancer, as determined by your doctor.


Doxorubicin seems to interfere with the growth of cancer cells, which are then eventually destroyed by the body. Since the growth of normal body cells may also be affected by doxorubicin, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects, like hair loss, may not be serious but may cause concern. Some effects may not occur until months or years after the medicine is used.


Before you begin treatment with doxorubicin, you and your doctor should talk about the good doxorubicin will do as well as the risks of using it.


Doxorubicin is to be administered only by or under the supervision of your doctor.


Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although these uses are not included in product labeling, doxorubicin is used in certain patients with the following medical conditions:


  • Autoimmune deficiency syndrome (AIDS)–associated Kaposi's sarcoma (a type of cancer of the skin and mucous membranes that is more common in patients with AIDS)

  • Cancer of the adrenal cortex (the outside layer of the adrenal gland)

  • Cancer of the cervix

  • Cancer of the endometrium

  • Cancer of the esophagus

  • Cancers of the head and neck

  • Cancer of the liver

  • Cancer of the pancreas

  • Cancer of the prostate

  • Cancer of the thymus (a small organ found under the breast bone)

  • Carcinoid tumors

  • Chronic lymphocytic leukemia (a type of cancer of the blood and lymph system)

  • Ewing's sarcoma (a type of cancer found in the bone)

  • Gestational trophoblastic tumors (tumors in the uterus or womb)

  • Hepatoblastoma (a certain type of liver cancer that occurs in children)

  • Multiple myeloma (a certain type of cancer of the blood)

  • Non–small cell lung cancer (a certain type of lung cancer usually associated with prior smoking, passive smoking, or radon exposure)

  • Retinoblastoma (a type of eye cancer found primarily in children)

  • Tumors in the ovaries

Before Using doxorubicin


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For doxorubicin, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to doxorubicin or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Heart problems are more likely to occur in children younger than 2 years of age, who are usually more sensitive to the effects of doxorubicin.


Geriatric


Heart problems are more likely to occur in the elderly, who are usually more sensitive to the effects of doxorubicin. The elderly may also be more likely to have blood problems.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersDStudies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy in a life threatening situation or a serious disease, may outweigh the potential risk.

Breast Feeding


Studies in women breastfeeding have demonstrated harmful infant effects. An alternative to this medication should be prescribed or you should stop breastfeeding while using doxorubicin.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving doxorubicin, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using doxorubicin with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Rotavirus Vaccine, Live

Using doxorubicin with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Adenovirus Vaccine Type 4, Live

  • Adenovirus Vaccine Type 7, Live

  • Bacillus of Calmette and Guerin Vaccine, Live

  • Cisplatin

  • Clozapine

  • Docetaxel

  • Glucosamine

  • Influenza Virus Vaccine, Live

  • Measles Virus Vaccine, Live

  • Mumps Virus Vaccine, Live

  • Paclitaxel

  • Rotavirus Vaccine, Live

  • Rubella Virus Vaccine, Live

  • Smallpox Vaccine

  • Stavudine

  • Trastuzumab

  • Typhoid Vaccine

  • Valspodar

  • Varicella Virus Vaccine

  • Warfarin

  • Yellow Fever Vaccine

  • Zidovudine

Using doxorubicin with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment for you. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Cyclosporine

  • Eltrombopag

  • Phenytoin

  • Sorafenib

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of doxorubicin. Make sure you tell your doctor if you have any other medical problems, especially:


  • Chickenpox (including recent exposure) or

  • Herpes zoster (shingles)—Risk of severe disease affecting other parts of the body

  • Gout or

  • Kidney stones—Doxorubicin may increase levels of uric acid in the body, which can cause gout or kidney stones

  • Heart disease—Risk of heart problems caused by doxorubicin may be increased

  • Liver disease—Effects of doxorubicin may be increased because of its slower removal from the body

Proper Use of doxorubicin


Doxorubicin is sometimes given together with certain other medicines. If you are receiving a combination of medicines, it is important that you receive each one at the proper time. If you are taking some of these medicines by mouth, ask your health care professional to help you plan a way to take them at the right times.


While you are using doxorubicin, your doctor may want you to drink extra fluids so that you will pass more urine. This will help prevent kidney problems and keep your kidneys working well.


Doxorubicin often causes nausea and vomiting. However, it is very important that you continue to receive the medication, even if you begin to feel ill. Ask your health care professional for ways to lessen these effects.


Dosing


The dose of doxorubicin will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of doxorubicin. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


Precautions While Using doxorubicin


It is very important that your doctor check your progress at regular visits to make sure that doxorubicin is working properly and to check for unwanted effects.


While you are being treated with doxorubicin, and after you stop treatment with it, do not have any immunizations (vaccinations) without your doctor's approval. Doxorubicin may lower your body's resistance, and there is a chance you might get the infection the immunization is meant to prevent. In addition, other persons living in your household should not take oral polio vaccine, since there is a chance they could pass the polio virus on to you. Also, avoid persons who have taken oral polio vaccine within the last several months. Do not get close to them, and do not stay in the same room with them for very long. If you cannot take these precautions, you should consider wearing a protective face mask that covers the nose and mouth.


Doxorubicin can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection. It can also lower the number of platelets, which are necessary for proper blood clotting. If this occurs, there are certain precautions you can take, especially when your blood count is low, to reduce the risk of infection or bleeding:


  • If you can, avoid people with infections. Check with your doctor immediately if you think you are getting an infection or if you get a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.

  • Check with your doctor immediately if you notice any unusual bleeding or bruising; black, tarry stools; blood in urine or stools; or pinpoint red spots on your skin.

  • Be careful when using a regular toothbrush, dental floss, or toothpick. Your medical doctor, dentist, or nurse may recommend other ways to clean your teeth and gums. Check with your medical doctor before having any dental work done.

  • Do not touch your eyes or the inside of your nose unless you have just washed your hands and have not touched anything else in the meantime.

  • Be careful not to cut yourself when you are using sharp objects such as a safety razor or fingernail or toenail cutters.

  • Avoid contact sports or other situations where bruising or injury could occur.

If doxorubicin accidentally seeps out of the vein into which it is injected, it may damage some tissues and cause scarring. Tell the doctor or nurse right away if you notice redness, pain, or swelling at the place of injection.


doxorubicin Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.



Check with your doctor immediately if any of the following side effects occur:


Less common
  • Fast or irregular heartbeat

  • pain at place of injection

  • shortness of breath

  • swelling of feet and lower legs

Rare
  • Black, tarry stools

  • blood in urine

  • pinpoint red spots on skin

  • unusual bleeding or bruising

  • wheezing

Check with your doctor as soon as possible if any of the following side effects occur:


More common
  • Sores in mouth and on lips

Less common
  • Cough or hoarseness accompanied by fever or chills

  • darkening or redness of skin (if you recently had radiation treatment)

  • fever or chills

  • joint pain

  • lower back or side pain accompanied by fever or chills

  • painful or difficult urination accompanied by fever or chills

  • red streaks along injected vein

  • stomach pain

Rare
  • Skin rash or itching

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Nausea and vomiting

Less common
  • Darkening of soles, palms, or nails

  • diarrhea

Doxorubicin causes the urine to turn reddish in color, which may stain clothes. This is not blood. It is to be expected and only lasts for 1 or 2 days after each dose is given.


doxorubicin often causes a temporary and total loss of hair. After treatment with doxorubicin has ended, normal hair growth should return.


After you stop using doxorubicin, it may still produce some side effects that need attention. During this period of time, check with your doctor immediately if you notice the following side effects:


  • Fast or irregular heartbeat

  • shortness of breath

  • swelling of feet and lower legs

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More doxorubicin Intravenous resources


  • Doxorubicin Intravenous Use in Pregnancy & Breastfeeding
  • Doxorubicin Intravenous Drug Interactions
  • Doxorubicin Intravenous Support Group
  • 2 Reviews for Doxorubicin Intravenous - Add your own review/rating


Compare doxorubicin Intravenous with other medications


  • Acute Lymphoblastic Leukemia
  • Acute Myeloblastic Leukemia
  • Bladder Cancer
  • Breast Cancer
  • Cancer
  • Hodgkin's Lymphoma
  • Lung Cancer
  • Lymphoma
  • Multiple Myeloma
  • Neuroblastoma
  • Osteosarcoma
  • Ovarian Cancer
  • Soft Tissue Sarcoma
  • Stomach Cancer
  • Thyroid Cancer
  • Wilms' Tumor

Tuesday, November 9, 2010

Vermifuge




Vermifuge may be available in the countries listed below.


In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Vermifuge



Levamisole

Levamisole hydrochloride (a derivative of Levamisole) is reported as an ingredient of Vermifuge in the following countries:


  • France

Niclosamide

Niclosamide is reported as an ingredient of Vermifuge in the following countries:


  • France

International Drug Name Search

Saturday, November 6, 2010

Oboliz




Oboliz may be available in the countries listed below.


Ingredient matches for Oboliz



Isoniazid

Isoniazid is reported as an ingredient of Oboliz in the following countries:


  • Greece

Rifampicin

Rifampicin is reported as an ingredient of Oboliz in the following countries:


  • Greece

International Drug Name Search

Friday, November 5, 2010

Penicillin VK




In some countries, this medicine may only be approved for veterinary use.


In the US, Penicillin VK (penicillin systemic) is a member of the drug class natural penicillins and is used to treat Actinomycosis, Anthrax, Anthrax Prophylaxis, Aspiration Pneumonia, Bacterial Infection, Clostridial Infection, Congenital Syphilis, Cutaneous Bacillus anthracis, Deep Neck Infection, Diphtheria, Endocarditis, Fusospirochetosis - Trench Mouth, Joint Infection, Leptospirosis, Lyme Disease - Arthritis, Lyme Disease - Carditis, Lyme Disease - Erythema Chronicum Migrans, Lyme Disease - Neurologic, Meningitis, Meningitis - Meningococcal, Meningitis - Pneumococcal, Neurosyphilis, Otitis Media, Pneumonia, Prevention of Perinatal Group B Streptococcal Disease, Rat-bite Fever, Rheumatic Fever Prophylaxis, Skin Infection, Strep Throat, Syphilis - Early, Syphilis - Latent, Tertiary Syphilis, Tonsillitis/Pharyngitis and Upper Respiratory Tract Infection.

US matches:

  • Penicillin VK

Ingredient matches for Penicillin VK



Phenoxymethylpenicillin

Phenoxymethylpenicillin potassium (a derivative of Phenoxymethylpenicillin) is reported as an ingredient of Penicillin VK in the following countries:


  • United States

International Drug Name Search

Thursday, November 4, 2010

Fluoxetin BMM Pharma




Fluoxetin BMM Pharma may be available in the countries listed below.


Ingredient matches for Fluoxetin BMM Pharma



Fluoxetine

Fluoxetine hydrochloride (a derivative of Fluoxetine) is reported as an ingredient of Fluoxetin BMM Pharma in the following countries:


  • Sweden

International Drug Name Search

Wednesday, November 3, 2010

Fluconazol




Fluconazol may be available in the countries listed below.


Ingredient matches for Fluconazol



Fluconazole

Fluconazole is reported as an ingredient of Fluconazol in the following countries:


  • Chile

  • Colombia

  • Netherlands

  • Norway

  • Romania

  • Slovakia

  • Venezuela

International Drug Name Search

Monday, November 1, 2010

Reotan




Reotan may be available in the countries listed below.


Ingredient matches for Reotan



Calcium Folinate

Calcium Folinate is reported as an ingredient of Reotan in the following countries:


  • Greece

International Drug Name Search

Sunday, October 31, 2010

Combicid




Combicid may be available in the countries listed below.


Ingredient matches for Combicid



Ampicillin

Ampicillin sodium salt (a derivative of Ampicillin) is reported as an ingredient of Combicid in the following countries:


  • Georgia

  • Turkey

Sulbactam

Sulbactam sodium salt (a derivative of Sulbactam) is reported as an ingredient of Combicid in the following countries:


  • Georgia

  • Turkey

Sultamicillin

Sultamicillin is reported as an ingredient of Combicid in the following countries:


  • Turkey

International Drug Name Search

Ranobi




Ranobi may be available in the countries listed below.


Ingredient matches for Ranobi



Carbazochrome

Carbazochrome sodium sulfonate (a derivative of Carbazochrome) is reported as an ingredient of Ranobi in the following countries:


  • Japan

International Drug Name Search

Friday, October 22, 2010

Aluminium Glycinate




Scheme

BP

ATC (Anatomical Therapeutic Chemical Classification)

A02AB07

CAS registry number (Chemical Abstracts Service)

0013682-92-3

Chemical Formula

C2-H6-Al-N-O4

Molecular Weight

135

Therapeutic Category

Antacid

Chemical Name

Aluminum, (glycinato-N,O)dihydroxy-, (T-4)-

Foreign Name

  • Aluminium glycinat-dihydroxid (German)

Generic Names

  • Aluminium dihydroxyaminoacetate (IS)
  • Aluminium-Glycinate Basic (IS)
  • Aluminium Glycinate (PH: BP 2010)
  • Dihydroxyaluminum Aminoacetate (PH: USP 32)

Brand Names

  • Acidrine
    Teofarma, Austria


  • Proacid (Aluminium Glycinate and Magnesium Carbonat)
    Ziololek, Poland

International Drug Name Search

Glossary

BPBritish Pharmacopoeia
ISInofficial Synonym
PHPharmacopoeia Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Wednesday, October 20, 2010

Vitamina B2




Vitamina B2 may be available in the countries listed below.


Ingredient matches for Vitamina B2



Riboflavin

Riboflavin is reported as an ingredient of Vitamina B2 in the following countries:


  • Peru

International Drug Name Search

Friday, October 15, 2010

Zonaker




Zonaker may be available in the countries listed below.


Ingredient matches for Zonaker



Hyaluronic Acid

Hyaluronic Acid sodium salt (a derivative of Hyaluronic Acid) is reported as an ingredient of Zonaker in the following countries:


  • Mexico

International Drug Name Search

Wednesday, October 13, 2010

Dimaphen DM


Generic Name: brompheniramine, dextromethorphan, and phenylephrine (brome fen IR a meen, dex troe metho OR fan, fen il EFF rin)

Brand Names: Alacol DM, Alahist DM, BP Allergy DM, BPM PE DM, Bromatan-DM, Bromtuss DM, BroveX PEB DM, Children's Cold & Cough DM, Cold & Cough Childrens, Dimaphen DM, Dimetapp Cold & Cough, Dimetapp DM Cold & Cough, DuraTan DM, Duravent DPB, Lohist-DM, Lortuss DM (obsolete), Tusdec-DM


What is Dimaphen DM (brompheniramine, dextromethorphan, and phenylephrine)?

Brompheniramine is an antihistamine that reduces the natural chemical histamine in the body. Histamine can produce symptoms of sneezing, itching, watery eyes, and runny nose.


Dextromethorphan is a cough suppressant. It affects the signals in the brain that trigger cough reflex.


Phenylephrine is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose).


Brompheniramine, dextromethorphan, and phenylephrine is used to treat sneezing, cough, runny or stuffy nose, itchy or watery eyes, hives, skin rash, itching, and other symptoms of allergies and the common cold.


Dextromethorphan will not treat a cough that is caused by smoking, asthma, or emphysema.


Brompheniramine, dextromethorphan, and phenylephrine may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about Dimaphen DM (brompheniramine, dextromethorphan, and phenylephrine)?


Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. Do not use any other over-the-counter cough, cold, or sleep medication without first asking your doctor or pharmacist. If you take certain products together you may accidentally take too much of a certain drug. Read the label of any other medicine you are using to see if it contains an antihistamine, decongestant, or cough suppressant. Do not use a cough or cold medicine if you have used an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate) within the past 14 days. Serious, life-threatening side effects can occur if you take cough or cold medicine before the MAO inhibitor has cleared from your body. Brompheniramine, dextromethorphan, and phenylephrine can cause side effects that may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be awake and alert. Avoid drinking alcohol. It can increase some of the side effects of this medication.

What should I discuss with my healthcare provider before taking Dimaphen DM (brompheniramine, dextromethorphan, and phenylephrine)?


Do not use a cough or cold medicine if you have used an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), rasagiline (Azilect), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate) within the past 14 days. Serious, life-threatening side effects can occur if you take cough or cold medicine before the MAO inhibitor has cleared from your body.

Before taking this medication, tell your doctor if you are allergic to brompheniramine, dextromethorphan, or phenylephrine, or if you have:


  • kidney disease;

  • liver disease;


  • diabetes;




  • glaucoma;




  • heart disease or high blood pressure;




  • diabetes;




  • a thyroid disorder;




  • a stomach ulcer or a stomach obstruction,




  • emphysema or chronic bronchitis; or




  • an enlarged prostate or urination problems.



If you have any of these conditions, you may need a dose adjustment or special tests to safely take this medication.


FDA pregnancy category C. This medication may be harmful to an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant during treatment. Brompheniramine, dextromethorphan, and phenylephrine can pass into breast milk and may harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.

Artificially-sweetened liquid forms of cough-and-cold medications may contain phenylalanine. This would be important to know if you have phenylketonuria (PKU). Check the ingredients and warnings on the medication label if you are concerned about phenylalanine.


How should I take Dimaphen DM (brompheniramine, dextromethorphan, and phenylephrine)?


Use this medication exactly as directed on the label or as it was prescribed for you. Do not take the medication in larger amounts, or take it for longer than recommended by your doctor.


Always ask a doctor before giving a cough or cold medicine to a child. Death can occur from the misuse of cough and cold medicines in very young children. Take this medicine with a full glass of water.

Measure the liquid form of this medicine with a special dose-measuring spoon or cup, not a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist where you can get one.


Take this medicine with food or milk if it upsets your stomach.

This medication can cause you to have unusual results with allergy skin tests. Tell any doctor who treats you that you are taking an antihistamine.


Talk with your doctor if your symptoms do not improve after 7 days of treatment, or if you have a fever with a headache, cough, or skin rash.

If you need to have any type of surgery, tell the surgeon ahead of time if you have taken a cold medicine within the past few days.


Store the medication at room temperature away from moisture and heat.

What happens if I miss a dose?


Since cough or cold medicine is usually taken only as needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the medicine at your next regularly scheduled time. Do not take extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine.

Overdose symptoms may include feeling restless or nervous, nausea, vomiting, stomach pain, dizziness, drowsiness, dry mouth, warmth or tingly feeling, or seizure (convulsions).


What should I avoid while taking Dimaphen DM (brompheniramine, dextromethorphan, and phenylephrine)?


This medication can cause side effects that may impair your thinking or reactions. Be careful if you drive or do anything that requires you to be awake and alert. Avoid drinking alcohol. It can increase some of the side effects of this medication.

Avoid using other medicines that make you sleepy (such as sleeping pills, pain medication, muscle relaxers, and medicine for seizures, depression or anxiety). They can add to sleepiness caused by brompheniramine, dextromethorphan, and phenylephrine.


Avoid taking diet pills, caffeine pills, or other stimulants (such as ADHD medications) without your doctor's advice. Taking a stimulant together with a decongestant can increase your risk of unpleasant side effects.


Do not use any other over-the-counter cough, cold, or sleep medication without first asking your doctor or pharmacist. If you take certain products together you may accidentally take too much of a certain drug. Read the label of any other medicine you are using to see if it contains an antihistamine, decongestant, or cough suppressant.

Dimaphen DM (brompheniramine, dextromethorphan, and phenylephrine) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using this medication and call your doctor at once if you have any of these serious side effects:

  • fast, pounding, or uneven heartbeat;




  • confusion, hallucinations, unusual thoughts or behavior;




  • severe dizziness, anxiety, restless feeling, or nervousness;




  • increased blood pressure (severe headache, blurred vision, trouble concentrating, chest pain, numbness, seizure);




  • confusion, hallucinations, unusual thoughts or behavior;




  • slow, shallow breathing;




  • urinating less than usual or not at all;




  • easy bruising or bleeding, unusual weakness, fever, chills, body aches, flu symptoms; or




  • nausea, stomach pain, low fever, loss of appetite, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes).



Less serious side effects may include:



  • blurred vision;




  • dry mouth;




  • nausea, stomach pain, constipation;




  • mild loss of appetite, stomach upset;




  • warmth, tingling, or redness under your skin;




  • sleep problems (insomnia);




  • restless or excitability (especially in children);




  • skin rash or itching;




  • dizziness, drowsiness;




  • problems with memory or concentration; or




  • ringing in your ears.



This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Dimaphen DM (brompheniramine, dextromethorphan, and phenylephrine)?


Before taking this medication, tell your doctor if you are using any of the following drugs:



  • an antidepressant;




  • a diuretic (water pill);




  • medication to treat irritable bowel syndrome;




  • celecoxib (Celebrex);




  • cinacalcet (Sensipar);




  • darifenacin (Enablex);




  • imatinib (Gleevec);




  • quinidine (Quinaglute, Quinidex);




  • ranolazine (Ranexa)




  • ritonavir (Norvir);




  • sibutramine (Meridia);




  • terbinafine (Lamisil);




  • medicines to treat high blood pressure;




  • aspirin or salicylates (such as Disalcid, Doan's Pills, Dolobid, Salflex, Tricosal, and others);




  • bladder or urinary medications such as oxybutynin (Ditropan, Oxytrol) or tolterodine (Detrol); or




  • a beta-blocker such as atenolol (Tenormin), carteolol (Cartrol), metoprolol (Lopressor, Toprol), nadolol (Corgard), propranolol (Inderal), sotalol (Betapace), timolol (Blocadren), and others.



This list is not complete and there may be other drugs that can interact with brompheniramine, dextromethorphan, and phenylephrine. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.



More Dimaphen DM resources


  • Dimaphen DM Side Effects (in more detail)
  • Dimaphen DM Use in Pregnancy & Breastfeeding
  • Dimaphen DM Drug Interactions
  • Dimaphen DM Support Group
  • 0 Reviews for Dimaphen DM - Add your own review/rating


  • Alacol DM Elixir MedFacts Consumer Leaflet (Wolters Kluwer)

  • Bromatan-DM Suspension MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Dimaphen DM with other medications


  • Cough and Nasal Congestion


Where can I get more information?


  • Your pharmacist can provide more information about brompheniramine, dextromethorphan, and phenylephrine.

See also: Dimaphen DM side effects (in more detail)


Ripercol L Piperazine




In some countries, this medicine may only be approved for veterinary use.

Ingredient matches for Ripercol L Piperazine



Levamisole

Levamisole hydrochloride (a derivative of Levamisole) is reported as an ingredient of Ripercol L Piperazine in the following countries:


  • United States

Piperazine

Piperazine dihydrochloride (a derivative of Piperazine) is reported as an ingredient of Ripercol L Piperazine in the following countries:


  • United States

International Drug Name Search

Tuesday, October 12, 2010

Triflusal Lareq




Triflusal Lareq may be available in the countries listed below.


Ingredient matches for Triflusal Lareq



Triflusal

Triflusal is reported as an ingredient of Triflusal Lareq in the following countries:


  • Spain

International Drug Name Search

Ron Acid


Generic Name: magaldrate (MAG al drate)

Brand Names: Ron Acid


What is Ron Acid (magaldrate)?

Magaldrate is an aluminum-containing antacid.


Magaldrate is used to treat heartburn, indigestion, or stomach upset.


Magaldrate may also be used for other purposes not listed in this medication guide.


What is the most important information I should know about Ron Acid (magaldrate)?


You should not use this medication if you are allergic to magaldrate.

Before you take magaldrate, tell your doctor if you have kidney disease, Alzheimer's dementia, severe constipation or diarrhea, stomach ulcer or intestinal bleeding, a blockage in your stomach or intestines, or a colostomy or ileostomy.


Do not take this medication for longer than 2 weeks without your doctor's advice. Call your doctor if your symptoms do not improve, or if they get worse while taking magaldrate. This medication can cause you to have unusual results with certain medical tests such as an x-ray, CT scan, or MRI taken using a radioactive dye. Be sure any doctor who treats you knows ahead of time that you are taking magaldrate.

Stop taking magaldrate and call your doctor if you have severe stomach pain or cramps, severe nausea or vomiting, bone pain or muscle weakness, mood changes, or swelling in your hands or feet.


What should I discuss with my health care provider before taking Ron Acid (magaldrate)?


You should not use this medication if you are allergic to magaldrate.

If you have certain conditions, you may need a dose adjustment or special tests to safely use this medication. Before you take magaldrate, tell your doctor if you have:



  • kidney disease;




  • Alzheimer's dementia;




  • severe constipation or diarrhea;




  • stomach ulcer or intestinal bleeding;




  • a blockage in your stomach or intestines; or




  • a colostomy or ileostomy.




FDA pregnancy category C. It is not known whether magaldrate is harmful to an unborn baby. Before taking this medication, tell your doctor if you are pregnant or plan to become pregnant during treatment. Magaldrate may pass into breast milk. Although it is not expected to cause harm to a nursing baby, do not use magaldrate without telling your doctor if you are breast-feeding a baby.

How should I take Ron Acid (magaldrate)?


Use this medication exactly as directed on the label, or as prescribed by your doctor. Do not use it in larger amounts or for longer than recommended.


Magaldrate is usually taken 20 to 60 minutes after a meal and at bedtime. Follow your doctor's instructions.


Shake the oral suspension (liquid) well just before you measure a dose. To be sure you get the correct dose, measure the liquid with a marked measuring spoon or medicine cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one. Do not take this medication for longer than 2 weeks without your doctor's advice. Call your doctor if your symptoms do not improve, or if they get worse while taking magaldrate. This medication can cause you to have unusual results with certain medical tests such as an x-ray, CT scan, or MRI taken using a radioactive dye. Be sure any doctor who treats you knows ahead of time that you are taking magaldrate. Store magaldrate at room temperature away from moisture and heat. Do not freeze.

What happens if I miss a dose?


Since magaldrate is used as needed, you may not be on a dosing schedule. If you are using the medication regularly, use the missed dose as soon as you remember. If it is almost time for your next dose, wait until then to use the medicine and skip the missed dose. Do not use extra medicine to make up the missed dose.


What happens if I overdose?


Seek emergency medical attention if you think you have used too much of this medicine.

Overdose symptoms may include severe constipation, diarrhea, cramps, or other stomach problems.


What should I avoid while taking Ron Acid (magaldrate)?


Avoid taking any other medications within 2 hours before or after you take magaldrate. Either magaldrate or the other medications may be less effective when taken at the same time.


Ron Acid (magaldrate) side effects


Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat. Stop using magaldrate and call your doctor at once if you have a serious side effect such as:

  • severe stomach pain, cramps, or bloating;




  • severe nausea or vomiting;




  • ongoing loss of appetite, weight loss;




  • severe constipation;




  • painful or difficult urination;




  • bone pain or muscle weakness;




  • mood changes; or




  • swelling in your hands or feet.



Less serious side effects may include:



  • mild constipation or diarrhea;




  • mild loss of appetite; or




  • light-colored stools.



This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.


What other drugs will affect Ron Acid (magaldrate)?


Tell your doctor about all other medications you use, especially:



  • ursodiol (Actigall, Urso);




  • ethambutol (Myambutol);




  • isoniazid;




  • ketoconazole (Nizoral);




  • mecamylamine (Inversine);




  • sodium polystyrene sulfonate (Kayexalate, Kionex);




  • tacrolimus (Prograf);




  • vitamin or mineral supplements that contain aluminum, calcium, or iron;




  • an antibiotic such as ciprofloxacin (Cipro), ofloxacin (Floxin), norfloxacin (Noroxin), levofloxacin (Levaquin), lomefloxacin (Maxaquin), and others;




  • drugs to treat Paget's disease or osteoporosis, such as alendronate (Fosamax), etidronate (Didronel), ibandronate (Boniva), risedronate (Actonel), or tiludronate (Skelid);




  • medicines containing phosphates, such as K-Phos, Neutra-Phos, and others;




  • methenamine (Hiprex, Mandelamine, Urex);




  • thyroid medications such as levothyroxine (Synthroid) or liothyronine (Cytomel); or




  • a tetracycline antibiotic such as demeclocycline (Declomycin), doxycycline (Adoxa, Doryx, Oracea, Vibramycin), minocycline (Dynacin, Minocin, Solodyn, Vectrin), or tetracycline (Brodspec, Panmycin, Sumycin, Tetracap, Helidac).



This list is not complete and there may be other drugs that can interact with magaldrate. Tell your doctor about all your prescription and over-the-counter medications, vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start a new medication without telling your doctor.



More Ron Acid resources


  • Ron Acid Side Effects (in more detail)
  • Ron Acid Use in Pregnancy & Breastfeeding
  • Ron Acid Drug Interactions
  • 0 Reviews for Ron Acid - Add your own review/rating


  • Magaldrate Suspension MedFacts Consumer Leaflet (Wolters Kluwer)



Compare Ron Acid with other medications


  • Indigestion


Where can I get more information?


  • Your pharmacist can provide more information about magaldrate.

See also: Ron Acid side effects (in more detail)


Sunday, October 10, 2010

Doven




Doven may be available in the countries listed below.


Ingredient matches for Doven



Diosmin

Diosmin is reported as an ingredient of Doven in the following countries:


  • Italy

International Drug Name Search

DDAVP Rhinal Tube


Generic Name: desmopressin (Nasal route, Oral route, Injection route)

des-moe-PRES-in

Injection route(Solution)

Desmopressin acetate is not indicated for the treatment of hemophilia A with factor VIII coagulant activity levels equal to or less than 5%, or for the treatment of hemophilia B, or in patients who have factor VIII antibodies .



Commonly used brand name(s)

In the U.S.


  • DDAVP

  • DDAVP Rhinal Tube

  • Minirin

  • Stimate

Available Dosage Forms:


  • Solution

  • Spray

  • Tablet

Therapeutic Class: Endocrine-Metabolic Agent


Pharmacologic Class: Vasopressin (class)


Uses For DDAVP Rhinal Tube


Desmopressin is a hormone taken through the nose, by mouth, or given by injection to prevent or control the frequent urination, increased thirst, and loss of water associated with diabetes insipidus (water diabetes). It is used also to control bed-wetting and frequent urination and increased thirst associated with certain types of brain injuries or brain surgery. Desmopressin works by acting on the kidneys to reduce the flow of urine.


Desmopressin is also given by injection to treat some patients with certain bleeding problems such as hemophilia or von Willebrand's disease.


Desmopressin is available only with your doctor's prescription.


Once a medicine has been approved for marketing for a certain use, experience may show that it is also useful for other medical problems. Although this use is not included in product labeling, desmopressin is used in certain patients to determine the cause of Cushing's syndrome.


Before Using DDAVP Rhinal Tube


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies performed to date have not demonstrated pediatrics-specific problems that would limit the usefulness of nasal desmopressin in children and infants. However, infants may be more sensitive to the effects of nasal desmopressin, which may require caution in patients receiving this medicine .


Appropriate studies performed to date have not demonstrated pediatrics-specific problems that would limit the usefulness of oral desmopressin in infants and children with diabetes insipidus. However, safety and efficacy have not been established in children below 6 years of age with bed-wetting problems .


Appropriate studies have not been performed on the relationship of age to the effects of desmopressin injection in infants below 3 months of age for the treatment of hemophilia A or Von Willebrand's disease, and in children below 12 years of age with diabetes insipidus. Safety and efficacy have not been established in these age groups .


Geriatric


Appropriate studies performed to date have not demonstrated geriatrics-specific problems that would limit the usefulness of desmopressin in the elderly. However, elderly patients are more likely to have age-related liver, kidney, or heart problems, which may require an adjustment of dosage in patients receiving desmopressin .


Pregnancy








Pregnancy CategoryExplanation
All TrimestersBAnimal studies have revealed no evidence of harm to the fetus, however, there are no adequate studies in pregnant women OR animal studies have shown an adverse effect, but adequate studies in pregnant women have failed to demonstrate a risk to the fetus.

Breast Feeding


Studies in women suggest that this medication poses minimal risk to the infant when used during breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.


Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:


  • Blood clots—Use with caution. Desmopressin injection may worsen this condition .

  • Cystic fibrosis or

  • Dehydration or

  • Fluid or electrolyte imbalance or

  • Heart failure—Loss of sodium from the blood and serious side effects may be more likely to occur in patients with these conditions .

  • Headache, severe, or migraine or

  • Heart or blood vessel disease or

  • High blood pressure—Large doses of desmopressin can cause an increase or decrease in blood pressure.

  • Hyponatremia, or history of or

  • Kidney problems—Desmopressin should NOT be used in patients with these conditions .

  • Stuffy nose caused by cold or allergy—May prevent nasal desmopressin from being absorbed through the lining of the nose into the blood stream.

Proper Use of desmopressin

This section provides information on the proper use of a number of products that contain desmopressin. It may not be specific to DDAVP Rhinal Tube. Please read with care.


Use this medicine only as directed. Do not use more of it and do not use it more often than your doctor ordered. To do so may increase the chance of side effects.


Your doctor may want you to decrease the amount of fluids that you drink while you are using this medicine .


For patients using the nasal solution form of this medicine:


  • This medicine comes with patient instructions. Read and follow these instructions carefully.

  • Before using the medicine, gently blow your nose to clear the nostrils.

  • If you are using the nasal spray for the first time, you will need to prime the spray. To do this, press the pump down four times or until some of the medicine sprays out. If you have not used the medicine for one week or longer, re-prime the pump by pressing once.

  • Do not use the nasal spray more times than the number indicated on the label. If you do, you may not receive the correct amount of medicine.

  • After using the nasal spray, wipe the tip of the bottle with a clean tissue and put the cap back on.

  • The Rhinal Tube is a soft plastic tube with numbers (doses) marked on the side. Draw the drops into the tube until the liquid reaches the number of your dose. Put one end of the tube into your nose and the other end into your mouth. Blow gently until all the medicine has sprayed into your nose. Do not let any medicine run down through the tube into your mouth.

  • After using the rhinal tube, wash it with water and shake thoroughly until no more water is left. Put the seal back on the dropper tip and close the bottle with the plastic cap .

For patients using the tablet form of this medicine:


  • Do not drink water or any other liquids from 1 hour before to 8 hours after taking the tablets .

For patients using the injection form of this medicine:


  • A nurse or other trained health professional will give you this medicine. Sometimes you, a family member, or a friend can also be taught to give your medicine .

Dosing


The dose of this medicine will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of this medicine. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For nasal dosage form (nasal solution):
    • For preventing or controlling diabetes insipidus (water diabetes):
      • Adults and teenagers—0.1 to 0.4 milliliters (ml) or 10 to 40 micrograms (mcg) given as a single dose or divided into two or three doses a day .

      • Children 3 months to 12 years of age— 0.05 to 0.3 milliliters (ml) or 5 to 30 micrograms (mcg) given as a single dose or divided into two doses a day .

      • Children up to 3 months of age—Use and dose must be determined by your doctor .



  • For oral dosage form (tablets):
    • For preventing or controlling diabetes insipidus (water diabetes):
      • Adults, teenagers, and children—At first, 0.05 milligram (mg) two times a day. Then, your doctor may change the dose to 0.1 to 0.8 mg. The dose may be divided into several doses a day.


    • For controlling bed-wetting:
      • Adults, teenagers, and children 6 years of age or older—At first, 0.2 mg once a day at bedtime. Then, your doctor may increase the dose to as much as 0.6 mg a day.

      • Children up to 6 years of age—Use and dose must be determined by your doctor .



  • For parenteral dosage form (injection):
    • For preventing or controlling frequent urination:
      • Adults and teenagers—2 to 4 mcg injected into a vein or under the skin. This dose is usually divided into two doses a day, one given in the morning, and the other given in the evening.

      • Children up to 12 years of age—Use and dose must be determined by your doctor .


    • For treating some bleeding problems such as hemophilia or von Willebrand's disease (Type I):
      • Adults, teenagers, and children 11 months of age or older weighing more than 10 kg (22 pounds)—The dose is based on body weight and must be determined by your doctor. It is usually 0.3 micrograms (mcg) per kilogram (kg) (0.14 mcg per pound) of body weight mixed in 50 milliliters (mL) of 0.9% sodium chloride. This solution is injected into a vein slowly over fifteen to thirty minutes. Your doctor may repeat this treatment if needed.

      • Children 3 months of age or older weighing 10 kg (22 pounds) or less—The dose is based on body weight and must be determined by your doctor. It is usually 0.3 micrograms (mcg) per kilogram (kg) (0.14 mcg per pound) of body weight mixed in 10 mL of 0.9% sodium chloride. This solution is injected into a vein slowly over fifteen to thirty minutes. Your doctor may repeat this treatment if needed.

      • Children up to 3 months of age—Use and dose must be determined by your doctor .



Missed Dose


If you miss a dose of this medicine, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Has a bulleted list describing how to handle missed doses for various possible dosing schedules.


Storage


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Store as directed on the label or by your health care professional.


Precautions While Using DDAVP Rhinal Tube


It is very important that your doctor check your progress at regular visits to make sure this medicine is working properly. Urine tests may be needed to check for unwanted effects .


This medicine lowers the amount of sodium in your blood. Check with your doctor right away if you have confusion, nausea, vomiting, muscle cramps or spasms, or unusual tiredness or weakness .


Check with your doctor right away and stop using this medicine if you have fever, severe vomiting or diarrhea, or other conditions that may make you thirsty (such as during hot weather or having a strenuous exercise). This medicine may cause fluid or electrolyte imbalance which can lead to seizures and other serious conditions .


Do not take other medicines unless they have been discussed with your doctor, especially medicines that can make your mouth dry. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements .


Desmopressin may cause a serious type of allergic reaction called anaphylaxis. Anaphylaxis can be life-threatening and requires immediate medical attention. Tell your doctor right away if you have a rash; itching; swelling of the face, tongue, and throat; trouble breathing; or chest pain after you use this medicine .


DDAVP Rhinal Tube Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


Rare
  • Chills

  • confusion

  • convulsions (seizures)

  • decreased urination

  • drowsiness

  • fast heartbeat

  • fever

  • headache (continuing)

  • shortness of breath, tightness in chest, trouble in breathing, or wheezing

  • skin rash, hives, or itching

  • weight gain (rapid)

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


Less common or rare
  • Abdominal or stomach cramps

  • flushing or redness of skin

  • nausea

  • pain in the vulva (genital area outside of the vagina)

With intranasal (through the nose) use
  • Cough

  • nosebleed

  • runny or stuffy nose

  • sneezing

  • sore throat

With intravenous use
  • Pain, redness, or swelling at place of injection

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: DDAVP side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More DDAVP Rhinal Tube resources


  • DDAVP Rhinal Tube Side Effects (in more detail)
  • DDAVP Rhinal Tube Use in Pregnancy & Breastfeeding
  • DDAVP Rhinal Tube Drug Interactions
  • DDAVP Rhinal Tube Support Group
  • 0 Reviews for DDAVP - Add your own review/rating


  • DDAVP Rhinal Tube nasal Concise Consumer Information (Cerner Multum)

  • Desmopressin Prescribing Information (FDA)

  • DDAVP MedFacts Consumer Leaflet (Wolters Kluwer)

  • DDAVP Prescribing Information (FDA)

  • DDAVP Concise Consumer Information (Cerner Multum)

  • Desmopressin Acetate Monograph (AHFS DI)

  • Minirin Spray MedFacts Consumer Leaflet (Wolters Kluwer)

  • Stimate Prescribing Information (FDA)

  • Stimate Spray MedFacts Consumer Leaflet (Wolters Kluwer)



Compare DDAVP Rhinal Tube with other medications


  • Diabetes Insipidus